Cytori to Webcast Third Quarter Financial Results on November 14
09 Noviembre 2018 - 7:30AM
Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live
webcast of its third quarter financial results and business update
on Wednesday, November 14, 2018 at 5:30 PM Eastern Time.
The dial-in information is as
follows:
Dial-In Number:
+1.877.402.3914
Conference ID: 9699923
Prior to the webcast at approximately 4:30 PM Eastern Time on
November 14, Cytori will issue its third quarter earnings release
which will review Cytori’s third quarter and year-to-date
performance. The webcast will be available both live and by
replay two hours after the call in the “Webcasts” section of the
company’s investor relations website.
About Cytori Therapeutics, Inc.
Cytori is developing, manufacturing, and commercializing
nanoparticle-delivered oncology drugs and autologous
adipose-derived regenerative cell (ADRC) therapies within its
Nanomedicine™ and Cell Therapy™ franchises, respectively.
Cytori Nanomedicine™ is focused on the liposomal encapsulation of
anti-neoplastic chemotherapy agents, which may enable the effective
delivery of the agents to target sites while reducing systemic
toxicity. The Cytori Nanomedicine™ product pipeline consists of
ATI-0918 pegylated liposomal doxorubicin hydrochloride for breast
cancer, ovarian cancer, multiple myeloma, and Kaposi’s sarcoma, a
complex/hybrid generic drug, and ATI-1123 patented
albumin-stabilized pegylated liposomal docetaxel for multiple solid
tumors. Cytori Cell Therapy™, prepared within several hours
with the proprietary Celution® System and administered to the
patient the same day, has been shown in preclinical and clinical
studies to act principally by improving blood flow, modulating the
immune system, and facilitating wound repair. As a result, Cytori
Cell Therapy™ may provide benefits across multiple disease states
and can be made available to the physician and patient at the
point-of-care. For more information, visit www.cytori.com.
Cytori Therapeutics, Inc.Tiago Girao,
1.858.458.0900ir@cytori.com
Cytori Therapeutics (NASDAQ:CYTX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Cytori Therapeutics (NASDAQ:CYTX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Cytori Therapeutics Inc (NASDAQ): 0 recent articles
Más de Artículos de Noticias